Company news
Imugene Ltd news in 2017
Imugene Ltd's news releases, calls and decks from 2017, newest first.
Rights Issue Results & Shortfall Notification
December 19, 2017
Imugene raises $8.7 million
November 22, 2017
Response to ASX Price Query
October 16, 2017
IMU Receives $1.1m R&D Tax Refund
October 10, 2017
First Patient Dosing Commences of HER-Vaxx
August 30, 2017
Imugene granted Canadian patent for Her-Vaxx cancer vaccine
July 21, 2017
Appendix 4C - quarterly and Commentry Q3
April 28, 2017
IMU Raises $3.0m from Options Plan
April 6, 2017
$1.35 million Options Underwritten
March 29, 2017
Half Year Report and Accounts
February 28, 2017
Intellectual Property Strengthened Around Lead Clinical Drug
February 26, 2017
BMC Cancer journal publishes encouraging HER-Vaxx research
February 12, 2017